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The N-methyl-D-aspartate (NMDA)-type glutamate receptor is one of three
major classes of receptors for glutamate,
the principle excitatory neurotransmitter
in the central nervous system. It plays a
key role in learning and in the formation
of memories by acting as a ‘‘coincidence
detector’’ that initiates changes in synaptic
strength that lead to the formation of new
neural networks (1). It is also an important
mediator of several forms of pathological
neuronal toxicity. The NMDA receptor
responds at a synapse only when the pre-
synaptic terminal releases glutamate at
the same time that the postsynaptic neu-
ron is strongly depolarized by the sum of
activating influences impinging on it. In
effect, it initiates the strengthening of all
synapses that depolarize the same postsyn-
aptic neuron at the same time and thus
triggers formation of a new, more stable
circuit. When the NMDA-receptor chan-
nel opens, it allows passage of calcium
ions, as well as sodium and potassium, into
the cell. The calcium ions trigger a cascade
of biochemical signaling reactions cata-
lyzed by enzymes located just underneath
the postsynaptic membrane. These reac-
tions modify other membrane channels in
the synapse, ultimately leading to a change
in the strength of the electrical signal
produced when the synapse is activated
again.
The processes of thinking, learning, and
remembering are subtle and complex.
Therefore, it isn’t surprising that the mag-
nitude and timing of calcium flux through
NMDA receptors are tightly regulated by
phosphorylation by several second-
messenger-regulated protein kinases. The
paper in this issue of PNAS by Li et al.
entitled ‘‘Regulation of NMDA receptors
by cyclin-dependent kinase-5’’ now pro-
vides evidence that a cyclin-dependent
kinase that is highly expressed in brain
also may be an important regulator of
NMDA-receptor function (2). The cyclin-
dependent kinases are a large family of 10
or more members that are known mostly
for their involvement in orchestrating
transitions in the cell cycle (3, 4). Cdk1 is
the mammalian orthologue of the yeast
cyclin-dependent protein kinase responsi-
ble for initiating the transition into mitosis
(cdc2ycdc28). Other members of the fam-
ily control critical functions, such as DNA
replication, during the cell cycle. Most
cdks are regulated by a family of small
proteins called cyclins that are synthesized
and degraded in a tightly controlled fash-
ion as the cell cycle progresses. Only a few
members of the family have functions
outside the cell cycle; cdk5 is one of them.
Its highest level of expression is in post-
mitotic neurons in developing and adult
brain. The cdk5 catalytic subunit alone has
no catalytic activity; however, it is not
regulated by cyclins. Instead, it is activated
by association with brain-specific regula-
tory proteins that have little sequence
similarity to cyclins but seem to assume a
cyclin-like fold (3). Cdk5 has many known
functions in the brain, including an essen-
tial role in neuronal migration during de-
velopment of the cortex (5, 6), regulation
of cadherin adhesion, regulation of actin,
neurofilament, and tubulin cytoskeletons,
and regulation of dopamine signaling (3).
In addition, cdk5 may mediate hyperphos-
phorylation of tau protein that leads to the
formation of paired helical filaments in
Alzheimer’s disease (7). The work by Li et
al. shows that cdk5 is concentrated to-
gether with the NMDA receptor at gluta-
matergic postsynaptic sites and can phos-
phorylate the cytosolic tail of a subunit of
the NMDA receptor. The authors also
show that roscovitine, an inhibitor of cdk5,
reduces current through the NMDA re-
ceptor and blocks induction of long-term
potentiation (LTP) in hippocampal slices.
Their results suggest that cdk5 is part of a
pathway that, directly or indirectly, regu-
lates the amplitude of current through
NMDA receptors.
Like most ligand-gated channels, the
NMDA receptor is an oligomer of four to
five individual subunits that come to-
gether in the membrane to form the chan-
nel (1). One of these subunits, NR1, is
necessary for channel function and is sim-
ilar in structure to the subunits of other
ligand-gated channels (8). However, the
four other principal subunits, termed
NR2A–D, are unique among ligand-gated
channels in having long extensions of their
carboxyl-terminal tails that protrude into
the cytoplasm beneath the membrane and
serve as anchoring points for signal trans-
ducing enzymes (see Fig. 1; refs. 9 and 10).
In the hippocampus and cortex, NR2A
and NR2B are the most prominent. The
’630-residue cytosolic tail of NR2A and
the ’650-residue tail of NR2B are homol-
ogous but are only ’30% identical in
sequence. The most similar regions are
clustered in small segments of the tails
(see Fig. 1). Thus, the two subunits may
interact with some of the same, and some
distinct, proteins. The tails of both sub-
units bind to the scaffold protein PSD-95
(11, 12) and also bind Ca21ycalmodulin-
dependent protein kinase II (CaMKII;
refs. 13 and 14), but the nature and
consequences of that interaction may
differ (15).
See companion article on page 12742.
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Fig. 1. Phosphorylation sites on the cytosolic tails
of NMDA-receptor subunits NR2A and NR2B. The
domain diagrams compare the cytosolic tail of
NR2A (residues 838-1464) and that of NR2B (resi-
dues 839-1482). Regions shown in red are 70%
identical; in gold, 50%; in yellow, 40%; and in light
blue, 20–30%. White regions show no similarity.
The positions of phosphorylation sites discussed in
the text are labeled, and the protein kinase be-
lieved to phosphorylate each is noted. Phosphory-
lation of Ser-1232 (in red) by Cdk5 is described by Li
et al. in this issue (2).
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Although a number of sites on the tails
of these two subunits have been shown to
be phosphorylated by specific protein ki-
nases (14, 16–21), evidence about the
functional significance of these modifica-
tions is still inconclusive. Perhaps the best
documented example of a functionally sig-
nificant phosphorylation is the up-
regulation of activity of NMDA receptors
through phosphorylation by the srcyfyn
family of cytosolic protein Tyr kinases (for
review, see ref. 22). The introduction of
src or a peptide that activates src-family
kinases into heterologous cells expressing
NMDA receptors increases NMDA-
evoked currents. Similar treatment of neu-
rons increases the NMDA-receptor com-
ponent of synaptically evoked currents.
The same effects can be seen after appli-
cation of these reagents to inside-out
membrane patches containing NMDA re-
ceptors. However, the functional signifi-
cance of these effects and the mechanisms
underlying them are uncertain. For exam-
ple, enhancement of recombinant NR1y
NR2A currents is blocked by mutating
specific Tyr residues in the cytosolic tail to
Phe (Y1105, Y1267, Y1387; ref. 17), sup-
porting the notion that the enhancement is
caused by Tyr phosphorylation. However,
the increased current is caused by a re-
duction of tonic, high-affinity, voltage-
independent blockade of the channels by
extracellular Zn21, an effect that is not
observed when recording from NMDA
receptors in intact neurons (23). To com-
plicate the interpretation further, the
principal site phosphorylated in NR2B in
vivo by the fyn Tyr kinase, a close relative
of src, does not correspond to the residues
that, when mutated in NR2A, block up-
regulation by src (Y1472; ref. 20). This
site, Tyr-1472, becomes more heavily
phosphorylated in
hippocampal slices
after induction of
LTP and after tran-
sient global ischemia
(20). The sequence
surrounding
Tyr-1472 in NR2A is
a consensus clathrin
adaptor-2 (AP2)-
binding domain that
can mediate NMDA-receptor internaliza-
tion if it is not masked by binding to the
PDZ domain of PSD-95 (24). The increase
in phosphorylation of the Tyr in the AP2-
binding domain after induction of LTP
suggests that phosphorylation of this site
may help to regulate turnover of the
NMDA receptor. In the same vein, Vissel
et al. (25) have reported recently that
dephosphorylation of a ring of Tyr resi-
dues in NMDA-receptor subunits NR1
and NR2A results in down-regulation of
recombinant NR1yNR2A receptors, ap-
parently by clathrin-mediated endocyto-
sis. These sites can be phosphorylated and
down-regulation can be blocked by the Src
and Fyn protein Tyr kinases.
Thus, although it is not yet clear which
phosphorylation sites are important for
physiological regulation of the NMDA
receptor or for assembly of its associated
signaling com-
plexes, it is appar-
ent that the recep-
tor can be
modified by a
complex, integra-
tive network of
phosphor ylation
and dephosphory-
lation. The organi-
zation and func-
tions of this network will be the focus of
much research over the next few years. In
particular, it will be interesting to see
whether the Ser site in NR2A that is
phosphorylated by cdk5 in heterologous
cells also is phosphorylated in neurons,
and whether phosphorylation of the site is
required for normal current through the
NMDA receptor.
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receptor can be modified by a
complex, integrative network of
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